Epigenetic changes in Mycobacterium tuberculosis and its host provide potential targets or biomarkers for drug discovery and clinical diagnosis

被引：12
|
作者：
Sui, Jing [1 ,2 ]
Qiao, Wenliang [3 ]
Xiang, Xinrong [1 ,2 ]
Luo, Youfu [1 ,2 ]
机构：
[1] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu 610041, Peoples R China
[2] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu 610041, Peoples R China
[3] Sichuan Univ, Lung Canc Ctr, Lab Lung Canc, Western China Hosp, Chengdu, Peoples R China
来源：
PHARMACOLOGICAL RESEARCH | 2022年 / 179卷
基金：
中国国家自然科学基金;
关键词：
Mycobacterium tuberculosis; Epigenetics; DNA methylation; Histone modification; MicroRNA; METALLOPROTEINASE-1; AND-3; EXPRESSION; RIBOSOMAL-RNA METHYLTRANSFERASE; NF-KAPPA-B; DNA METHYLATION; IMMUNE-RESPONSES; CPG DNA; MATRIX METALLOPROTEINASES; DIRECTED THERAPY; INNATE IMMUNITY; VITAMIN-D;
D O I：
10.1016/j.phrs.2022.106195
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Tuberculosis infection caused by the contagious pathogen Mycobacterium tuberculosis (MTB) is one of the ancient diseases in the world. The problem of drug resistance is a difficulty in tuberculosis treatment. MTB engendered epigenetic changes play vital parts in escaping the host immune response and bring about the persistence as well as bacterial expansion. This article describes the epigenetic changes that occur in the pathogen MTB and its host during infection, including DNA methylation, histone modification and microRNA, and summarizes their research progress in drug discovery and tuberculosis diagnosis, providing new ideas and strategies to combat against drug-resistant tuberculosis.
引用
收藏
页数：13
相关论文
共 50 条
  • [1] Proteases in Mycobacterium tuberculosis pathogenesis: potential as drug targets
    Roberts, David M.
    Personne, Yoann
    Ollinger, Juliane
    Parish, Tanya
    FUTURE MICROBIOLOGY, 2013, 8 (05) : 621 - 631
  • [2] Genome analyses of 174 strains of Mycobacterium tuberculosis provide insight into the evolution of drug resistance and reveal potential drug targets
    Verma, Helianthous
    Nagar, Shekhar
    Vohra, Shivani
    Pandey, Shubhanshu
    Lal, Devi
    Negi, Ram Krishan
    Lal, Rup
    Rawat, Charu Dogra
    MICROBIAL GENOMICS, 2021, 7 (03):
  • [3] Mycobacterium tuberculosis Lipolytic Enzymes as Potential Biomarkers for the Diagnosis of Active Tuberculosis
    Brust, Belinda
    Lecoufle, Melanie
    Tuaillon, Edouard
    Dedieu, Luc
    Canaan, Stephane
    Valverde, Viviane
    Kremer, Laurent
    PLOS ONE, 2011, 6 (09):
  • [4] Host factors subverted by Mycobacterium tuberculosis: Potential targets for host directed therapy
    Kalra, Rashi
    Tiwari, Drishti
    Dkhar, Hedwin Kitdorlang
    Bhagyaraj, Ella
    Kumar, Rakesh
    Bhardwaj, Anshu
    Gupta, Pawan
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2023, 42 (01) : 43 - 70
  • [5] In Silico Drug Discovery Strategies Identified ADMET Properties of Decoquinate RMB041 and Its Potential Drug Targets against Mycobacterium tuberculosis
    Knoll, Kirsten E.
    van der Walt, Mietha M.
    Loots, Du Toit
    MICROBIOLOGY SPECTRUM, 2022, 10 (02):
  • [6] Advances in Computational Studies of Potential Drug Targets in Mycobacterium tuberculosis
    Alladi, Subha Mahadevi
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2018, 18 (13) : 1062 - 1074
  • [7] Cofactor Biosynthetic Pathways in Mycobacterium tuberculosis as Potential Drug Targets
    Pandey, Shilpika
    Gaur, Sarthak
    Topno, Neha
    Chopra, Sidharth
    Dasgupta, Arunava
    CURRENT RESPIRATORY MEDICINE REVIEWS, 2014, 10 (02) : 97 - 108
  • [8] Epigenetic Mechanisms Induced by Mycobacterium tuberculosis to Promote Its Survival in the Host
    Thomas, Shwetha Susan
    Abhinand, Kuniyil
    Menon, Arjun M.
    Nair, Bipin G.
    Kumar, Geetha B.
    Arun, K. B.
    Edison, Lekshmi K.
    Madhavan, Aravind
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (21)
  • [9] Mycobacterium tuberculosis adhesins: potential biomarkers as anti-tuberculosis therapeutic and diagnostic targets
    Govender, Viveshree S.
    Ramsugit, Saiyur
    Pillay, Manormoney
    MICROBIOLOGY-SGM, 2014, 160 : 1821 - 1831
  • [10] In vitro drug discovery models for Mycobacterium tuberculosis relevant for host infection
    Parish, Tanya
    EXPERT OPINION ON DRUG DISCOVERY, 2020, 15 (03) : 349 - 358
12345